evergladesbiopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Everglades
Description Home Our Company Additional Resurces Publications Contact Everglades Biopharma is a leader in developing ligand-based therapies. A proprietary technology
Keywords N/A
Server Information
WebSite evergladesbiopharma faviconevergladesbiopharma.com
Host IP 192.254.186.158
Location United States
Related Websites
Site Rank
More to Explore
evergladesbiopharma.com Valuation
US$830
Last updated: 2023-05-08 03:13:42

evergladesbiopharma.com has Semrush global rank of 0. evergladesbiopharma.com has an estimated worth of US$ 830, based on its estimated Ads revenue. evergladesbiopharma.com receives approximately 95 unique visitors each day. Its web server is located in United States, with IP address 192.254.186.158. According to SiteAdvisor, evergladesbiopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$830
Daily Ads Revenue US$0
Monthly Ads Revenue US$23
Yearly Ads Revenue US$276
Daily Unique Visitors 6
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
evergladesbiopharma.com. 7199 A evergladesbiopharma.com. 7199 IP: 192.254.186.158
evergladesbiopharma.com. 86400 NS evergladesbiopharma.com. 86400 NS Record: ns6337.hostgator.com.
evergladesbiopharma.com. 86400 NS evergladesbiopharma.com. 86400 NS Record: ns6338.hostgator.com.
evergladesbiopharma.com. 14400 MX evergladesbiopharma.com. 14400 MX Record: 0 mail.evergladesbiopharma.com.
evergladesbiopharma.com. 14400 TXT evergladesbiopharma.com. 14400 TXT Record: v=spf1 a mx include:websitewelcome.com ~all
HtmlToTextCheckTime:2023-05-08 03:13:42
Home Our Company Additional Resurces Publications Contact Everglades Biopharma is a leader in developing ligand-based therapies. A proprietary technology of ligandomics enables systematic identification of disease-specific cellular ligands as therapeutic targets. Therapies can be rationally developed by overexpressing beneficial ligands or blocking detrimental ligands. Therapies against disease-specific ligands is expected to have higher therapeutic efficacy and less side effects than against non-disease-specific ligands. A leading product of the Company is a therapeutic antibody against a novel angiogenic ligand that is upregulated in neovascular disease conditions but not expressed in normal vessels. This antibody drug is under development for the therapy of neovascular age-related macular degeneration (AMD), diabetic macular edema and cancer. © Copyright Everglades Biopharma. All rights
HTTP Headers
HTTP/1.1 200 OK
Date: Fri, 29 Oct 2021 05:56:20 GMT
Server: Apache
Upgrade: h2,h2c
Connection: Upgrade
Last-Modified: Sun, 28 Jan 2018 00:12:27 GMT
Accept-Ranges: bytes
Content-Length: 3434
Vary: Accept-Encoding
Content-Type: text/html
evergladesbiopharma.com Whois Information
Domain Name: EVERGLADESBIOPHARMA.COM
Registry Domain ID: 1982588651_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-09-29T21:35:53Z
Creation Date: 2015-11-20T14:45:15Z
Registry Expiry Date: 2021-11-20T14:45:15Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS6337.HOSTGATOR.COM
Name Server: NS6338.HOSTGATOR.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T20:21:37Z <<<